Asthma

Join Clinical Trials for Asthma

In General

Asthma makes breathing difficult for millions of Americans, and its incidence is on the rise in both adults and children. Although the coughing, wheezing, and chest tightness associated with asthma attacks can be frustrating to deal with and at times, difficult to manage, it is important to not lose hope and to maintain a positive outlook.

Research related to asthma offers promising signs of improved therapies, management strategies, and an overall better understanding of the nature of asthma in the coming years.

Currently, considerable research is being conducted on asthma from a number of perspectives.

Some research is working to better identify the environmental factors that trigger asthma symptoms, as well as the genetic characteristics that cause people to be more susceptible to those triggers.

In addition, research is being conducted to test newer methods of treating asthma symptoms, and ways of preventing or delaying their onset. 

Continued … Asthma Clinical Trials (Click to Open)

Join Clinical Trials for Asthma

What do Typical Clinical Trials for Asthma involve?

When participating in a clinical trial designed to investigate some aspect related to Clinical trials for asthmaasthma, there are a few basic tests and procedures you may receive; however, the ultimate design of the particular study will determine which specific procedures you will undergo.

On a basic level, however, you can expect any one or combination of the following: allergy testing; lung exam with a stethoscope; blood tests to check for oxygen and other gas levels; blood tests to check for immune system cells; chest x-rays; and lung function tests (which measure how well your lungs take in an release air, as well as how efficiently they move oxygen into and out of your blood).

Examples of Clinical Trials for Asthma

Currently, research related to asthma covers a broad range of topics. Specific examples might include the following:

  • The impact of urban versus rural living on the development of food allergies in children.
  • The effects of maternal smoking during pregnancy on rates of asthma in children and teenagers.
  • The association between the immune system and the development of asthma
  • Characteristics of the immune system that may lead to the development of more effective allergy medications.
  • Head-to-head comparison of an established asthma treatment with a new, investigational drug delivered through an inhaler during a severe asthma attack.

Suggested Search Terms:

 “asthma children,” “severe asthma,” “asthma control,” “asthma exacerbation,” “asthma triggers,” “asthma smoking,” “asthma acute,” “asthma occupation,” and “asthma management.”

Current Search Term: “Asthma”



Disclosure of Smoking in Adolescents With Asthma


Condition:   Asthma
Interventions:   Other: Group 1 - Parents will be present for the Questionnaire.;   Other: Group 2- Parents will not be present for the Questionnaire
Sponsors:   Imperial College London;   The Whittington Hospital NHS Trust
Recruiting - verified October 2016


Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma


Condition:   Asthma
Interventions:   Device: TURBUHALER®;   Device: SPIROMAX®
Sponsor:   Fundación Pública Andaluza Progreso y Salud
Recruiting - verified November 2016


Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer


Condition:   Asthma
Interventions:   Device: oxyhydrogen;   Device: oxygen
Sponsors:   Shanghai Asclepius Meditec Inc.;   The First Affiliated Hospital of Guangzhou Medical University;   Second Affiliated Hospital of Guangzhou Medical University;   The Second Hospital of Hebei Medical University;   Tianjin Medical University General Hospital;   West China Hospital
Recruiting - verified August 2016


Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma


Condition:   Asthma
Interventions:   Drug: QVM149;   Drug: QVM149;   Drug: QMF149;   Drug: QMF149;   Drug: salmeterol/fluticasone
Sponsor:   Novartis Pharmaceuticals
Recruiting - verified May 2017


A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma


Condition:   Asthma
Intervention:   Drug: MEDI9929, 140 mg
Sponsors:   MedImmune LLC;   Amgen
Completed - verified January 2017


Registry for Asthma Characterization and Recruitment 2


Condition:   Asthma
Intervention:  
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Inner-City Asthma Consortium
Recruiting - verified August 2016


Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma


Condition:   Asthma
Interventions:   Drug: QGE031;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Terminated - verified February 2017


Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management


Condition:   Asthma
Interventions:   Other: AsthmaCare mobile health application;   Other: Asthma education
Sponsor:   David Stukus
Enrolling by invitation - verified January 2017


Home Centered Comprehensive Care (HCCC) for Children With Asthma


Condition:   Asthma
Interventions:   Other: Standard comprehensive care;   Other: enhanced comprehensive care
Sponsors:   The University of Texas Health Science Center, Houston;   Centers for Medicare and Medicaid Services;   National Institutes of Health (NIH)
Completed - verified May 2017


Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population


Condition:   Asthma
Intervention:  
Sponsor:   AstraZeneca
Completed - verified November 2016


The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China


Condition:   Asthma
Intervention:  
Sponsor:   AstraZeneca
Completed - verified November 2016


Triple in Asthma Dose Finding


Condition:   Asthma
Interventions:   Drug: CHF 5259 plus Foster 100/6 µg;   Drug: Foster 100/6 µg
Sponsor:   Chiesi Farmaceutici S.p.A.
Completed - verified March 2017


Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma


Condition:   Asthma
Interventions:   Drug: Placebo;   Drug: MEDI9929 - Low Dose IP;   Drug: MEDI9929 - Medium Dose IP;   Drug: MEDI9929 - High Dose IP
Sponsors:   MedImmune LLC;   Amgen
Completed - verified March 2017


Comparison of Nebulizers in ED in Pediatric Asthma Patients


Condition:   Asthma
Interventions:   Device: Hudson RCI® nebulizer;   Device: NebuTech® HDN® nebulizer;   Drug: Albuterol
Sponsor:   Seton Healthcare Family
Completed - verified October 2016


Identification of Asthma Phenotypes in Severe Asthmatics


Condition:   Asthma
Intervention:  
Sponsor:   Singapore General Hospital
Recruiting - verified February 2017


Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma


Condition:   Asthma
Intervention:  
Sponsors:   National Jewish Health;   MedImmune LLC
Completed - verified March 2017


Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma


Condition:   Asthma
Intervention:   Behavioral: Reinforced Asthma Education
Sponsors:   University of Louisville;   Passport Health
Completed - verified July 2012


Improving Asthma Outcomes Through Cultural Competence Training for Physicians


Condition:   Asthma
Interventions:   Behavioral: PACE;   Behavioral: PACE Plus
Sponsor:   University of Michigan
Completed - verified March 2017


Women of Color and Asthma Control


Condition:   Asthma
Intervention:   Behavioral: Telephone counseling intervention
Sponsor:   University of Michigan
Completed - verified June 2016


Staccato Loxapine Pulmonary Safety in Patients With Asthma


Condition:   Asthma
Interventions:   Drug: Inhaled loxapine @ 0 & 10 h;   Drug: Inhaled placebo @ 2 & 10 hours
Sponsor:   Alexza Pharmaceuticals, Inc.
Completed - verified August 2009


Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma


Condition:   Asthma
Interventions:   Drug: INTRAVENOUS GSK679586;   Drug: INTRAVENOUS PLACEBO;   Drug: FLUTICASONE PROPIONATE
Sponsor:   GlaxoSmithKline
Completed - verified April 2017


Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors


Condition:   Asthma
Intervention:  
Sponsors:   Arkansas Children's Hospital Research Institute;   Robert Wood Johnson Foundation
Completed - verified January 2017


Cell Biology of Steroid Resistant Asthma


Condition:   Asthma
Intervention:   Drug: prednisone
Sponsors:   National Jewish Health;   Genentech, Inc.
Completed - verified March 2017


Disease Modifying Genes in Severe Asthma


Condition:   Asthma
Intervention:  
Sponsor:   New York University School of Medicine
Active, not recruiting - verified February 2017


Study Of Asthma In Patients Of African Descent


Condition:   Asthma
Interventions:   Drug: fluticasone propionate/salmeterol powder;   Drug: fluticasone propionate powder
Sponsor:   GlaxoSmithKline
Completed - verified January 2017

Refine Your Search Advanced Search